FIRST PHYSICIANS CAPITAL GROUP, INC. Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulati

Show all filings for TRI-ISTHMUS GROUP, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for TRI-ISTHMUS GROUP, INC. 1-Oct-2009Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulati Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All informati...
Click here to read the whole Article (external link)

TIGroup Elects Five Directors, Changes Name to First Physicians Capital Group, Inc.

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Tri-Isthmus Group, Inc. (TIGroup) (OTCBB: TISG - News), an operator of healthcare services firms primarily in rural and suburban markets in the U.S., announced today the re-election of four directors and the election of a new director to serve on the company’s board. The newly elected director is William A. Houlihan. The re-elected directors are Chairman and CEO David Hirschhorn, Todd Parker, Dr. Robert N. Schwartz and Richardson E. Sells. Additional information on the directors may be found at http://www.firstphysicianscapitalgroup.com. Houlihan will serve as the board’s financial expert and will be a member of the Audit Committee. He has previously served as chief fina...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits

Show all filings for TRI-ISTHMUS GROUP, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for TRI-ISTHMUS GROUP, INC. 9-Sep-2009Unregistered Sale of Equity Securities, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information p...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 10-Q, Quarterly Report

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the related notes appearing elsewhere herein. FORWARD LOOKING STATEMENTS Depending on the market for our stock and other conditional tests, a specific safe harbor under the Private Securities Litigation Reform Act of 1995 may be available, and the discussion in this Quarterly Report on Form 10-Q (this "Form 10-Q") contains forward-looking statements made pursuant to such safe harbor provisions. This Form 10-Q contains forward-looking statements, and such statements should not be unduly relied upon. Forward-looking statements can be identified by the use of words such as "may," "will," "could," "should," "anticipates," "believes," "estimates," "expects," "intends," "plans" and variations thereof or of similar expressions. All forward-looking statements included in this Form 10-Q are based on information available to us on the date hereof. We assume no obligation to update any such forward-looking statements. Our actual results in future periods could differ materially from those indicated in such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, possession of significant voting control over us by the holders of our Series 5-A Preferred Stock and Series 6-A Preferred Stock, our limited cash resources, our ability to redirect and finance our business, our significant corporate expenses and expenses related to the Securities and Exchange Commission (the "SEC") and limited revenue to offset these expenses, availability of appropriate prospective acquisitions or investment opportunities, litigation, other risks discussed in o...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities On June 8, 2009, Tri-Isthmus Group, Inc., a Delaware corporation (the "Registrant"), entered into a Series 6-A Preferred Stock and Warrant Purchase Agreement (the "Purchase Agreement"), a form of which is attached hereto as Exhibit 10.1, with an investor (the "Purchaser"), whereby the Registrant issued and sold 350 shares of its Series 6-A Convertible Preferred Stock, par value $0.01 per share (the "Series 6-A Preferred Stock"), and warrants to purchase an aggregate of 210,000 shares of its common stock, par value $0.01 per share (the "Common Stock"), at an exercise price of $0.50 per share, exercisable in full at any time for a period of two years from the date of issuance, in substantially the form attached hereto as Exhibit 10.2 (the "Warrants"), in a private placement for an aggregate purchase price of $350,000.00. The purchase price for the Series 6-A Preferred Stock and Warrants was $1,000.00 per unit (each, a "Unit"), with each Unit consisting of one (1) share of Series 6-A Preferred Stock and a warrant to purchase six hundred (600) shares of Common Stock. The Purchaser represented to the Registrant in writing that he is an "Accredited Investor," as that term is defined in Rule 501(a) of Regulation D, promulgated under the Securities Act of 1933, as amended (the "Securities Act"). On June 10, 2009, in consideration for the future strategic advice and assistance to be provided by certain members of the newly-created Medical Advisory Board (the "Medical Advisory Board"), the Registrant issued warrants to purchase 150,000 shares of Common Stock, at an initial purchase price of $0.625 per share, in substantially the form attached hereto as Exhibit 10.3 (the "Medical Advisory Board Warrants"). The Medical Advisory Board Warrants expire three years from the date of issuance, and shall vest according to the following schedule: (i) one-...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 8-K, Amendment or Waiver to Code of Ethics

Show all filings for TRI-ISTHMUS GROUP, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for TRI-ISTHMUS GROUP, INC. 21-May-2009Amendment or Waiver to Code of Ethics Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purpose...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 10-Q, Quarterly Report

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the related notes appearing elsewhere herein. FORWARD LOOKING STATEMENTS Depending on the market for our stock and other conditional tests, a specific safe harbor under the Private Securities Litigation Reform Act of 1995 may be available, and the discussion in this Quarterly Report on Form 10-Q (this "Form 10-Q") contains forward-looking statements made pursuant to such safe harbor provisions. This Form 10-Q contains forward-looking statements, and such statements should not be unduly relied upon. Forward-looking statements can be identified by the use of words such as "may," "will," "could," "should," "anticipates," "believes," "estimates," "expects," "intends," "plans" and variations thereof or of similar expressions. All forward-looking statements included in this Form 10-Q are based on information available to us on the date hereof. We assume no obligation to update any such forward-looking statements. Our actual results in future periods could differ materially from those indicated in such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, possession of significant voting control over us by the holders of our Series 5-A Preferred Stock and Series 6-A Preferred Stock, our limited cash resources, our ability to redirect and finance our business, our significant corporate expenses and expenses related to the Securities and Exchange Commission (the "SEC") and limited revenue to offset these expenses, availability of appropriate prospective acquisitions or investment opportunities, litigation, other risks discussed in ou...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits

Show all filings for TRI-ISTHMUS GROUP, INC. | Request a Trial to NEW EDGAR Online Pro Form 8-K for TRI-ISTHMUS GROUP, INC. 5-May-2009Unregistered Sale of Equity Securities, Financial Statements and Exhibits Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information pr...
Click here to read the whole Article (external link)

TRI-ISTHMUS GROUP, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-B

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On April 14, 2009, Tri-Isthmus Group, Inc. (the "Registrant") closed a transaction in which the Registrant entered into the following three (3) promissory notes: (i) a convertible promissory note, dated as of March 31, 2009, with Frank Darras, Trustee of the Darras Family Trust ("Darras"), in the principal amount of $100,000.00 (the "Darras Note"); (ii) a convertible promissory note, dated as of March 31, 2009, with SFV, Incorporated, a California corporation ("SFV"), in the principal amount of $50,000.00 (the "SFV Note"); and (iii) a convertible promissory note, dated as of April 14, 2009, with an IRA established by Neal Katz, in the name of NFS LLC/FMTC Rol IRA FBO Neal Katz A/C LMG-001902 ("Katz"), in the principal amount of $50,000.00 (the "Katz Note") (each, a "Note" and collectively, the "Notes," a form of which is attached hereto as Exhibit 10.1). Darras, SFV, and Katz are each a "Holder" and are collectively referred to herein as the "Holders." The Notes were issued by the Registrant in conjunction with the Registrant's bridge financing that commenced in February of 2009 (the "Bridge Financing"). The Darras Note and the SFV Note become due and payable on December 31, 2009, and the Katz Note becomes due and payable on January 14, 2010 (collectively, the "Maturity Dates"); provided however, that the term of each of the Notes may be extended for an additional three months at the Registrant's discretion. In the event the Registrant exercises this option, it will be required to issue warrants to the Holders to purchase shares of the Registrant's common stock, par value $0.01 per share (the "Common Stock"), as follows: (i) Darras - 25,000 shares at a price of $0.50 per share, and 16,667 shares at a price of $0.7...
Click here to read the whole Article (external link)